Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hepatoprotective effect of perioperative steroid administration before major hepatectomy with extrahepatic bile duct resection
jRCTs041180181Completed
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of hydrocortisone in biliary cancer, hilar cholangiocarcinoma (HC) and hepatobiliary cancer (HBC) (2 arms). Primary endpoint: Liver failure. Started May 2017; status: completed.
02
Drugs
hydrocortisone
03
Conditions
biliary cancerhilar cholangiocarcinoma (HC)hepatobiliary cancer (HBC)
Beyond the preview
Go deeper on jRCTs041180181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041180181.